Sipai Health Technology Co., Ltd. (HKG:0314)
Hong Kong · Delayed Price · Currency is HKD 2.710
-0.030 (-1.11%)
Jan 21, 2026, 4:08 PM HKT
Sipai Health Technology Revenue
Sipai Health Technology had revenue of 1.22B CNY in the half year ending June 30, 2025, a decrease of -49.79%. This brings the company's revenue in the last twelve months to 3.43B, down -26.14% year-over-year. In the year 2024, Sipai Health Technology had annual revenue of 4.57B, down -3.11%.
Revenue (ttm)
3.43B CNY
Revenue Growth
-26.14%
P/S Ratio
0.54
Revenue / Employee
1.06M CNY
Employees
3,247
Market Cap
2.02B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.57B | -146.67M | -3.11% |
| Dec 31, 2023 | 4.71B | 592.63M | 14.39% |
| Dec 31, 2022 | 4.12B | 645.55M | 18.58% |
| Dec 31, 2021 | 3.47B | 774.28M | 28.68% |
| Dec 31, 2020 | 2.70B | 1.66B | 159.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JD Health International | 71.34B |
| BeOne Medicines AG | 38.69B |
| Alibaba Health Information Technology | 36.09B |
| Sino Biopharmaceutical | 33.49B |
| CSPC Pharmaceutical Group | 28.65B |
| WuXi Biologics | 21.98B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| Innovent Biologics | 12.52B |